Vascepa is a prescription medication used to reduce the risk of cardiovascular events in certain adult patient groups [2]. It contains the active ingredient icosapent ethyl, which is an omega-3 fatty acid [1]. According to the FDA, there are no known drug interactions with Vascepa [2]. However, it is important to note that patients should always inform their healthcare provider about all medications they are taking, including over-the-counter medications, supplements, and herbal remedies, to avoid any potential interactions [2].

The FDA has approved Vascepa for use in certain adult patient groups, including those with established cardiovascular disease or with diabetes and two or more additional risk factors for cardiovascular disease [2]. The medication has been shown to reduce the risk of cardiovascular events such as heart attack and stroke in these patient groups [2].

According to a study published in the National Center for Biotechnology Information, Vascepa has a low potential for drug interactions due to its unique mechanism of action [3]. The study suggests that the medication may even have potential benefits in combination with other drugs, such as statins, which are commonly used to lower cholesterol levels [3].

In summary, there are no known drug interactions with Vascepa, according to the FDA [2]. However, patients should always inform their healthcare provider about all medications they are taking to avoid any potential interactions [2]. A study suggests that Vascepa may have potential benefits in combination with other drugs, such as statins [3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups
[3] https://www.ncbi.nlm.nih.gov/books/NBK425699/